Reported Consolidated quarterly numbers for Panacea Biotec are:Net Sales at Rs 125.36 crore in March 2020 up 4.82% from Rs. 119.60 crore in March 2019.
Quarterly Net Loss at Rs. 69.70 crore in March 2020 down 138.6% from Rs. 180.57 crore in March 2019.
EBITDA stands negative at Rs. 4.89 crore in March 2020 up 96.45% from Rs. 137.86 crore in March 2019.
Panacea Biotec shares closed at 206.35 on June 29, 2020 (NSE) and has given 58.12% returns over the last 6 months and 31.31% over the last 12 months.
| Panacea Biotec | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'20 | Dec'19 | Mar'19 | | Net Sales/Income from operations | 125.36 | 167.74 | 119.60 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 125.36 | 167.74 | 119.60 | | EXPENDITURE | | Consumption of Raw Materials | 43.04 | 54.77 | 58.23 | | Purchase of Traded Goods | 2.28 | 3.67 | 4.25 | | Increase/Decrease in Stocks | -5.77 | -6.16 | 16.48 | | Power & Fuel | -- | -- | -- | | Employees Cost | 38.04 | 36.70 | 34.11 | | Depreciation | 10.05 | 10.73 | 12.86 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 70.64 | 41.92 | 146.63 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -32.92 | 26.11 | -152.96 | | Other Income | 17.98 | 3.23 | 2.24 | | P/L Before Int., Excpt. Items & Tax | -14.94 | 29.34 | -150.72 | | Interest | 44.46 | 47.24 | 23.99 | | P/L Before Exceptional Items & Tax | -59.40 | -17.90 | -174.71 | | Exceptional Items | -- | -- | 360.85 | | P/L Before Tax | -59.40 | -17.90 | 186.14 | | Tax | 9.15 | 2.31 | 2.63 | | P/L After Tax from Ordinary Activities | -68.55 | -20.21 | 183.51 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -1.31 | -1.18 | -3.05 | | Net Profit/(Loss) For the Period | -69.86 | -21.39 | 180.46 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | 0.16 | 0.07 | 0.11 | | Net P/L After M.I & Associates | -69.70 | -21.32 | 180.57 | | Equity Share Capital | 6.13 | 6.13 | 6.13 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -11.38 | -3.48 | 29.98 | | Diluted EPS | -11.38 | -3.48 | 29.98 | | EPS After Extra Ordinary | | Basic EPS | -11.38 | -3.48 | 29.98 | | Diluted EPS | -11.38 | -3.48 | -29.98 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
First Published on Jun 30, 2020 02:11 pm
